Les anti-inflammatoires non stéroïdiens doivent-ils être utilisés de manière continue dans la spondylarthrite ankylosante ?

van der Heijde, 2005, Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study, Arthritis Rheum, 52, 1205, 10.1002/art.20985 Dougados, 2001, Efficacy of celecoxib, a cyclo-oxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional non-steroidal anti-inflammatory drug, Arthritis Rheum, 44, 180, 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K Calin, 1974, Double-bind cross-over trial of flurbiprofen and phenylbutazone in ankylosing spondylitis, Br Med J, 4, 496, 10.1136/bmj.4.5943.496 van der Heijde, 2011, Assessment of SpondyloArthritis international Society. 2010 update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis, Ann Rheum Dis, 70, 905, 10.1136/ard.2011.151563 Massó González, 2010, Variability among non-steroidal anti-inflammatory drugs in risk of upper gastrointestinal bleeding, Arthritis Rheum, 62, 1592, 10.1002/art.27412 Trelle, 2011, Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis, BMJ, 342, c7086, 10.1136/bmj.c7086 Henry, 1997, Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study, Br J Clin Pharmacol, 44, 85, 10.1046/j.1365-2125.1997.00631.x Braun, 2011, 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Ann Rheum Dis, 70, 896, 10.1136/ard.2011.151027 Wanders, 2005, Non-steroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial, Arthritis Rheum, 52, 1756, 10.1002/art.21054 Poddubnyy, 2012, Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort, Ann Rheum Dis, 71, 1616, 10.1136/annrheumdis-2011-201252 Haroon, 2011, Continuance of non-steroidal anti-inflammatory drugs may reduce radiographic progression in ankylosing spondylitis patients on biological therapy, Arthritis Rheum Boersma, 1976, Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone, Scand J Rheumatol, 5, 60 Wanders, 2004, What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter, Arthritis Rheum, 50, 2622, 10.1002/art.20446 Kroon, 2012, Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis, Ann Rheum Dis, 71, 1623, 10.1136/annrheumdis-2012-201370 Luyten, 2007, A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip, Ann Rheum Dis, 66, 99, 10.1136/ard.2006.052308 Strand, 2011, Treatment of osteoarthritis with continuous versus intermittent celecoxib, J Rheumatol, 38, 2625, 10.3899/jrheum.110636 Zhang, 2002, Cyclo-oxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair, J Clin Invest, 109, 1405, 10.1172/JCI0215681 Wendling, 2013, Do non-steroidal anti-inflammatory drugs have disease-modifying effects in spondyloarthritis?, Joint Bone Spine, 80, 563, 10.1016/j.jbspin.2013.06.003 Soubrier, 2013, Vascular effects of non-steroidal anti-inflammatory drugs, Joint Bone Spine, 80, 358, 10.1016/j.jbspin.2012.12.002